Brief: Neurobo Pharmaceuticals Announces 1-For-8 Reverse Stock Split
Dec 19 (Reuters) - Neurobo Pharmaceuticals Inc NRBO.O :
* NEUROBO PHARMACEUTICALS ANNOUNCES 1-FOR-8 REVERSE STOCK
SPLIT
* NEUROBO PHARMACEUTICALS INC - BEGINNING ON DECEMBER 21,
2023,
COMPANY'S COMMON STOCK WILL TRADE ON NASDAQ CAPITAL MARKET ON A
SPLIT ADJUSTED BASIS
Source text for Eikon: ID:nPnbNJHzha
Further company coverage: NRBO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on MetaVia
See all newsMetaVia Inc reports results for the quarter ended June 30 - Earnings Summary
MetaVia Q2 net loss widens on higher R&D spending
MetaVia Inc expected to post a loss of 82 cents a share - Earnings Preview
Brief: Biostem Technologies Announces Appointment Of Three New Members To Its Board Of Directors
MetaVia Q1 net loss widens slightly as expenses rise